Clinical Trial Update: Effect of Fimasartan on Extended RAS and Vascular Functions in Patients With Type 2 Diabetes and Hypertension [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effect of fimasartan on extended RAS and vascular functions in patients with type 2 diabetes and hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Hypertension
• Type 2 Diabetes Mellitus

Drugs mentioned

• Fimasartan (fimasartan)

Snippet

Sponsor: Seoul National University Bundang Hospital | Conditions: Hypertension, Atherosclerosis | Phase 4 | Status: UNKNOWN